2‐Undecanone induces ferroptosis via the STAT3 / GPX4 pathway to enhance sensitivity of renal cell carcinoma to sunitinib
BioFactors · 2025
DOI: 10.1002/biof.70016 ↗Kurz gefasst
Fachartikel in der Zeitschrift BioFactors, 2025. Verfasst von Zixuan Chen und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Urology, Tongren Hospital Shanghai Jiao Tong University School of Medicine, Shanghai, China. Hauptthemen laut MEDLINE: Sunitinib, Ferroptosis, Carcinoma, Renal Cell, STAT3 Transcription Factor. Die Arbeit wurde bisher 9-mal zitiert (Crossref) und nennt 52 Literaturangaben. Gefördert von: the National Natural Science Foundation of China, Research Fund of Shanghai Tongren Hospital, Shanghai Jiaotong University School of Medicine.
Abstract (Originalsprache)
The development of resistance significantly reduces the efficacy of targeted therapies, such as sunitinib, in renal cell carcinoma (RCC) patients, emphasizing the need for novel therapeutic agents. Natural products, known for their diverse chemical structures and mechanisms of action, offer promising anti‐tumor potential with favorable safety profiles and lower toxicity compared to synthetic drugs. 2‐Undecanone, a natural compound extracted from Houttuynia cordata Thunb., has demonstrated anti‐tumor effects, but its specific role in RCC treatment remains unclear. In this study, we integrated network pharmacology with in vitro experiments to explore the mechanisms underlying 2‐Undecanone's effects on RCC. Our results reveal that 2‐Undecanone effectively inhibits RCC cell viability, proliferation, and migration. Mechanistically, we discovered that 2‐Undecanone induces ferroptosis in RCC cells by promoting reactive oxygen species (ROS) generation, intracellular Fe 2+ accumulation, glutathione (GSH) production, lipid peroxidation, and modulation of the STAT3/GPX4 signaling pathway. Furthermore, 2‐Undecanone lowers the IC50 value of sunitinib in RCC cells, enhancing their sensitivity to this targeted therapy. Additionally, 2‐Undecanone potentiates sunitinib‐induced ferroptosis. In summary, our research reveals that 2‐Undecanone enhances the sensitivity of RCC cells to sunitinib through targeting the STAT3/GPX4 pathway, providing new insights into potential therapeutic strategies for RCC.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Urology, Tongren Hospital Shanghai Jiao Tong University School of Medicine, Shanghai, China.
- Department of General Surgery, Tongren Hospital Shanghai Jiao Tong University School of Medicine, Shanghai, China.
- School of Health Policy and Management, Chinese Academy of Medical Sciences & Peking Union Medical College, Beijing, China.
- Center of Structural Heart Disease, Zhongnan Hospital of Wuhan University, Wuhan, China.
ORCID-Profile: Zixuan Chen
Förderung
- the National Natural Science Foundation of China
- Research Fund of Shanghai Tongren Hospital, Shanghai Jiaotong University School of Medicine
Zitieren
APA
Chen, Z., Han, C., Xie, H., Chen, X., Zhang, H., Sun, Z., & Liu, M. (2025). 2‐Undecanone induces ferroptosis via the STAT3 / GPX4 pathway to enhance sensitivity of renal cell carcinoma to sunitinib. BioFactors. https://doi.org/10.1002/biof.70016
Vancouver
Chen Z, Han C, Xie H, Chen X, Zhang H, Sun Z, et al. 2‐Undecanone induces ferroptosis via the STAT3 / GPX4 pathway to enhance sensitivity of renal cell carcinoma to sunitinib. BioFactors. 2025. doi:10.1002/biof.70016
BibTeX
@article{Chen2025,
author = {Chen, Zixuan and Han, Chengtao and Xie, Huiwen and Chen, Xingyu and Zhang, Haojie and Sun, Zongrun and Liu, Min},
title = {2‐Undecanone induces ferroptosis via the STAT3 / GPX4 pathway to enhance sensitivity of renal cell carcinoma to sunitinib},
journal = {BioFactors},
year = {2025},
doi = {10.1002/biof.70016}
}
EUVIMED